As Electronic Health Records (EHRs) become more prolific, their use and value in ongoing and new clinical trials becomes more important and also a point of confusion and contention on data quality and privacy concerns in the industry. A new document released by the US Food and Drug Administration is intended as guidance for principle […]
Read More